Students can’t stand them. But campus presidents can’t live without them.
Immunic raised funds to support Phase 3 clinical trials of vidofludimus calcium for MS and transition into a commercial-stage company.
Honeywell (NASDAQ:HON) demonstrates industrial resilience and capital stability amid Nasdaq Futures positioning.